Nathaniel I. Martin

5.0k citations

135 papers · 3.4k indexed · h-index 35

Co-authors: John C. Vederas Kamaleddin H. M. E. Tehrani Matthijs J. van Haren Eefjan Breukink Thomas M. Wood Michael A. Marletta Sylvie Garneau‐Tsodikova Joshua J. Woodward
Topics: Antibiotic Resistance in Bacteria (38 papers)Antimicrobial Peptides and Activities (22 papers)Microbial Natural Products and Biosynthesis (17 papers)
Cited by: Molecular Medicine Microbiology Applied Microbiology and Biotechnology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Nathaniel I. Martin

130 papers receiving 3.4k citations

Peers

Countries citing papers authored by Nathaniel I. Martin

Since Specialization

Citations

This map shows the geographic impact of Nathaniel I. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel I. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel I. Martin more than expected).

Fields of papers citing papers by Nathaniel I. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel I. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel I. Martin. The network helps show where Nathaniel I. Martin may publish in the future.

Co-authorship network of co-authors of Nathaniel I. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel I. Martin. A scholar is included among the top collaborators of Nathaniel I. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel I. Martin. Nathaniel I. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and Evaluation of Carbapenem/Metallo‐β‐Lactamase Inhibitor Conjugates 2024 ·ChemMedChem ·Meiling Gao,(unknown),(unknown),(unknown),Paolo Innocenti,Nathaniel I. Martin	2
2	Targeting N-Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors 2024 ·Antibiotics ·(unknown),Tihomir Tomašič,Marko Anderluh,(unknown),(unknown),(unknown),Nathaniel I. Martin,Roland J. Pieters,(unknown),(unknown)	2
3	Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro 2024 ·Human Cell ·Valentina Pozzi,Elisa Molinelli,Roberto Campagna,(unknown),Monia Cecati,(unknown),Davide Sartini,Gaia Goteri,Nathaniel I. Martin,Matthijs J. van Haren,Eleonora Salvolini,Oriana Simonetti,Annamaria Offidani,Monica Emanuelli	5
4	In vivo biodistribution of kinetically stable Pt₂L₄ nanospheres that show anti-cancer activity 2023 ·Chemical Science ·Eduard O. Bobylev,(unknown),Simon Mathew,David A. Poole,(unknown),Nathaniel I. Martin,Bas de Bruin,Alexander Kros,Joost N. H. Reek	14
5	Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy 2022 ·Chemical Science ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Zheng Zhong,Yong‐Xin Li,(unknown),Mario van der Stelt,Stephen A. Cochrane,Nathaniel I. Martin	23
6	Synthetic Studies with Bacitracin A and Preparation of Analogues Containing Alternative Zinc Binding Groups 2022 ·ChemBioChem ·(unknown),(unknown),Matthijs J. van Haren,Nathaniel I. Martin	7
7	Mechanistic insights into the C₅₅-P targeting lipopeptide antibiotics revealed by structure–activity studies and high-resolution crystal structures 2022 ·Chemical Science ·Thomas M. Wood,(unknown),(unknown),(unknown),(unknown),(unknown),Nicholas M. Pearce,Martin Lutz,Johan Kemmink,(unknown),Leendert W. Hamoen,B.J.C. Janssen,Nathaniel I. Martin	16
8	A Direct Assay for Measuring the Activity and Inhibition of Coactivator-Associated Arginine Methyltransferase 1 2022 ·Biochemistry ·Yurui Zhang,Matthijs J. van Haren,(unknown),N. Troffer-Charlier,Vincent Cura,J. Cavarelli,Nathaniel I. Martin	2
9	Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics 2021 ·Journal of Medicinal Chemistry ·Yongzhi Gao,Matthijs J. van Haren,(unknown),Paolo Innocenti,Yurui Zhang,Davide Sartini,Roberto Campagna,Monica Emanuelli,Richard B. Parsons,Willem Jespers,Hugo Gutiérrez‐de‐Terán,Gerard J. P. van Westen,Nathaniel I. Martin	54
10	Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors 2021 ·ChemBioChem ·Yurui Zhang,(unknown),Matthijs J. van Haren,N. Troffer-Charlier,Vincent Cura,J. Cavarelli,Nathaniel I. Martin	5
11	Macrocyclic peptides as allosteric inhibitors of nicotinamide N -methyltransferase (NNMT) 2021 ·RSC Chemical Biology ·Matthijs J. van Haren,Yurui Zhang,(unknown),(unknown),Yongzhi Gao,Łukasz Mateuszuk,(unknown),Agnieszka Kij,Roberto Campagna,Davide Sartini,Monica Emanuelli,Stefan Chłopicki,Seino A. K. Jongkees,Nathaniel I. Martin	49
12	Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity 2021 ·Biomolecules ·Matthijs J. van Haren,Yongzhi Gao,(unknown),Roberto Campagna,Davide Sartini,Monica Emanuelli,Łukasz Mateuszuk,Agnieszka Kij,Stefan Chłopicki,(unknown),Raymond M. Schiffelers,Nathaniel I. Martin	36
13	The Cell Envelope Stress Response of Bacillus subtilis towards Laspartomycin C 2020 ·Antibiotics ·(unknown),Thomas M. Wood,Susanne Gebhard,Nathaniel I. Martin,Georg Fritz	8
14	A β-hairpin epitope as novel structural requirement for protein arginine rhamnosylation 2020 ·Chemical Science ·(unknown),Thomas M. Wood,Johan Kemmink,(unknown),(unknown),Jürgen Lassak,Nathaniel I. Martin,Marthe T. C. Walvoort	4
15	The contribution of achiral residues in the laspartomycin family of calcium-dependent lipopeptide antibiotics 2019 ·Organic & Biomolecular Chemistry ·Thomas M. Wood,(unknown),Nathaniel I. Martin	9
16	Novel Carbapenemases FLC-1 and IMI-2 Encoded by an Enterobacter cloacae Complex Isolated from Food Products 2019 ·Antimicrobial Agents and Chemotherapy ·Michael S. M. Brouwer,Kamaleddin H. M. E. Tehrani,Michel Rapallini,Yvon Geurts,Arie Kant,Frank Harders,Vida Mashayekhi,Nathaniel I. Martin,Alex Bossers,Dik Mevius,Ben Wit,Kees Veldman	21
17	Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7 2017 ·ACS Infectious Diseases ·(unknown),(unknown),(unknown),(unknown),Zishuo Cheng,(unknown),Hao Yang,Mahesh Aitha,M. Rachel Mehaffey,Jennifer S. Brodbelt,Kamaleddin H. M. E. Tehrani,Nathaniel I. Martin,Robert A. Bonomo,Richard C. Page,David L. Tierney,Walter Fast,Gerard D. Wright,Michael W. Crowder	47
18	Discovery of Small Molecules That Induce Lysosomal Cell Death in Cancer Cell Lines Using an Image-Based Screening Platform 2016 ·Assay and Drug Development Technologies ·Romina J. Pagliero,Diego S. D’Astolfo,Daphne Lelieveld,(unknown),Sonja Aits,Marja Jäättelä,Nathaniel I. Martin,Judith Klumperman,David A. Egan	17
19	Site‐Specific Immobilization of the Peptidoglycan Synthase PBP1B on a Surface Plasmon Resonance Chip Surface 2016 ·ChemBioChem ·(unknown),(unknown),Alexander J. F. Egan,B.J.C. Janssen,Nathaniel I. Martin,Waldemar Vollmer,Eefjan Breukink	13
20	Charting the interactome of PDE3A in human cells using an IBMX based chemical proteomics approach 2015 ·Molecular BioSystems ·Eleonora Corradini,(unknown),Ulrike Leurs,Albert J. R. Heck,Nathaniel I. Martin,Arjen Scholten	7

About Nathaniel I. Martin

Nathaniel I. Martin is a scholar working on Molecular Medicine, Microbiology and Applied Microbiology and Biotechnology, having authored 135 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (38 papers), Antimicrobial Peptides and Activities (22 papers) and Microbial Natural Products and Biosynthesis (17 papers). The work is most often cited by research in Molecular Medicine (621 citations), Microbiology (463 citations) and Applied Microbiology and Biotechnology (84 citations). Nathaniel I. Martin has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include John C. Vederas, Kamaleddin H. M. E. Tehrani, Matthijs J. van Haren, Eefjan Breukink, Thomas M. Wood, Michael A. Marletta, Sylvie Garneau‐Tsodikova, Joshua J. Woodward, Peter ‘t Hart and Frank J. Dekker. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact